Mody TD - Search Results

1

Validation and use of three complementary analytical methods (LC-FLS, LC-MS/MS and ICP-MS) to evaluate the pharmacokinetics, biodistribution and stability of motexafin gadolinium in plasma and tissues.

Miles DR, Mesfin M, Mody TD, Stiles M, Lee J, Fiene J, Denis B, Boswell GW. Miles DR, et al. Among authors: mody td. Anal Bioanal Chem. 2006 May;385(2):345-56. doi: 10.1007/s00216-006-0414-5. Epub 2006 Apr 12. Anal Bioanal Chem. 2006. PMID: 16609840

2

Quantitation of motexafin lutetium in human plasma by liquid chromatography-tandem mass spectrometry and inductively coupled plasma-atomic emission spectroscopy.

Miles D, Mody TD, Hatcher LI, Fiene J, Stiles M, Lin PP, Lee JW. Miles D, et al. Among authors: mody td. AAPS PharmSci. 2003;5(3):E23. doi: 10.1208/ps050323. AAPS PharmSci. 2003. PMID: 14621958 Free PMC article.

3

Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI.

Young SW, Qing F, Harriman A, Sessler JL, Dow WC, Mody TD, Hemmi GW, Hao Y, Miller RA. Young SW, et al. Among authors: mody td. Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6610-5. doi: 10.1073/pnas.93.13.6610. Proc Natl Acad Sci U S A. 1996. PMID: 8692865 Free PMC article.

4

Lutetium texaphyrin (PCI-0123): a near-infrared, water-soluble photosensitizer.

Young SW, Woodburn KW, Wright M, Mody TD, Fan Q, Sessler JL, Dow WC, Miller RA. Young SW, et al. Among authors: mody td. Photochem Photobiol. 1996 Jun;63(6):892-7. doi: 10.1111/j.1751-1097.1996.tb09647.x. Photochem Photobiol. 1996. PMID: 8992510

5

Phototherapy of cancer and atheromatous plaque with texaphyrins.

Woodburn KW, Fan Q, Kessel D, Wright M, Mody TD, Hemmi G, Magda D, Sessler JL, Dow WC, Miller RA, Young SW. Woodburn KW, et al. Among authors: mody td. J Clin Laser Med Surg. 1996 Oct;14(5):343-8. doi: 10.1089/clm.1996.14.343. J Clin Laser Med Surg. 1996. PMID: 9612202

6

Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies.

Traynor AM, Thomas JP, Ramanathan RK, Mody TD, Alberti D, Wilding G, Bailey HH. Traynor AM, et al. Among authors: mody td. Invest New Drugs. 2011 Apr;29(2):316-22. doi: 10.1007/s10637-009-9364-z. Epub 2009 Dec 9. Invest New Drugs. 2011. PMID: 19997959 Free PMC article. Clinical Trial.

7

Reaction chemistry of metallotexaphyrins: the synthesis and characterization of the first meso-oxotexaphlorin.

Wang Z, Fu L, Mody TD. Wang Z, et al. Among authors: mody td. Chem Commun (Camb). 2002 Apr 7;(7):678-9. doi: 10.1039/b108914p. Chem Commun (Camb). 2002. PMID: 12119671

8

Preclinical evaluation of gadolinium (III) texaphyrin complex. A new paramagnetic contrast agent for magnetic resonance imaging.

Young SW, Sidhu MK, Qing F, Muller HH, Neuder M, Zanassi G, Mody TD, Hemmi G, Dow W, Mutch JD, et al. Young SW, et al. Among authors: mody td. Invest Radiol. 1994 Mar;29(3):330-8. doi: 10.1097/00004424-199403000-00013. Invest Radiol. 1994. PMID: 8175308

9

Nuclear magnetic relaxation dispersion studies of water-soluble gadolinium(III)-texaphyrin complexes.

Geraldes CF, Sherry AD, Vallet P, Maton F, Muller RN, Mody TD, Hemmi G, Sessler JL. Geraldes CF, et al. Among authors: mody td. J Magn Reson Imaging. 1995 Nov-Dec;5(6):725-9. doi: 10.1002/jmri.1880050618. J Magn Reson Imaging. 1995. PMID: 8748493

10

Mn(II)-texaphyrin as a catalyst for the decomposition of peroxynitrite.

Shimanovich R, Hannah S, Lynch V, Gerasimchuk N, Mody TD, Magda D, Sessler J, Groves JT. Shimanovich R, et al. Among authors: mody td. J Am Chem Soc. 2001 Apr 18;123(15):3613-4. doi: 10.1021/ja005856i. J Am Chem Soc. 2001. PMID: 11472141 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters